The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System

被引：36

作者：

Oh, Kyung Taek ^{[2
]}

Baik, Hye Jung ^{[1
]}

Lee, A. Hyeong ^{[1
]}

Oh, Young Taik ^{[3
]}

Youn, Yu Seok ^{[4
]}

Lee, Eun Seong ^{[1
]}

机构：

[1] Catholic Univ Korea, Div Biotechnol, Bucheon Si 420743, Gyeonggi Do, South Korea

[2] Chung Ang Univ, Coll Pharm, Seoul 155756, South Korea

[3] Yonsei Univ, Coll Med, Dept Diagnost Radiol, Seoul 120752, South Korea

[4] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2009年 / 10卷 / 09期

关键词：

multi-drug resistance; nanoparticle; tumor treatment; drug delivery system; MULTIFUNCTIONAL POLYMERIC MICELLE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; IN-VIVO; LIPOSOMAL DOXORUBICIN; BLOCK-COPOLYMERS; CANCER-THERAPY; CELL-LINES; SOLID TUMORS; EFFLUX PUMP;

D O I：

10.3390/ijms10093776

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Medical applications of nanoparticular systems have attracted considerable attention because of their potential use in therapeutic targeting of disease tissues and their lower level of toxicity against healthy tissue, relative to traditional pharmaceutical drugs. The use of nanoparticular systems has been shown to overcome the limitations of most anticancer drugs in clinical applications. In particular, the improved performance of smarted nanoparticular system for solving the drug resistance problems that typically interrupt tumor treatment has provided a promising strategy for successful tumor chemotherapy. This review highlights recent studies that have examined the therapeutic effect of nanoparticular systems on drug-resistant tumors and presents insight on how they work.

引用

页码：3776 / 3792

页数：17

共 76 条

[31] Cell-cell contacts prevent anoikis in primary human colonic epithelial cells [J].

Hofmann, Claudia ;

Obermeier, Florian ;

Artinger, Monika ;

Hausmann, Martin ;

Falk, Werner ;

Schoelmerich, Juergen ;

Rogler, Gerhard ;

Grossmann, Johannes .

GASTROENTEROLOGY, 2007, 132 (02) :587-600

[32]

HYAFIL F, 1993, CANCER RES, V53, P4595

[33]

Izquierdo MA, 1996, INT J CANCER, V65, P230

[34] Pluronic® block copolymers for overcoming drug resistance in cancer [J].

Kabanov, AV ;

Batrakova, EV ;

Alakhov, VY .

ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :759-779

[35] Pluronic® block copolymers in drug delivery:: From micellar nanocontainers to biological response modifiers [J].

Kabanov, AV ;

Alakhov, VY .

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (01) :1-72

[36] DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1 [J].

Kannan, K ;

Kaminski, N ;

Rechavi, G ;

Jakob-Hirsch, J ;

Amariglio, N ;

Givol, D .

ONCOGENE, 2001, 20 (26) :3449-3455

[37] Doxorubicin-Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double-Targeting Folate Receptor and Early Endosomal pH [J].

Kim, Dongin ;

Lee, Eun Seong ;

Oh, Kyung Taek ;

Gao, Zhong Gao ;

Bae, You Han .

SMALL, 2008, 4 (11) :2043-2050

[38] Recent advances in understanding the cell death pathways activated by anticancer therapy [J].

Kim, R .

CANCER, 2005, 103 (08) :1551-1560

[39] Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells [J].

Kobayashi, Tomotaka ;

Ishida, Tatsuhiro ;

Okada, Yurie ;

Ise, Saori ;

Harashima, Hideyoshi ;

Kiwada, Hiroshi .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 329 (1-2) :94-102

[40] Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis [J].

Konig, A ;

Menzel, T ;

Lynen, S ;

Wrazel, L ;

Rosen, A ;

AlKatib, A ;

Raveche, E ;

Gabrilove, JL .

LEUKEMIA, 1997, 11 (02) :258-265

← 1 2 3 4 5 6 7 8 →